The Microfluidic Devices Market To See An Influx Of Big Data In The Healthcare Cloud

The global microfluidic devices market is expected to reach US$ 6 Bn in 2021. Global microfluidic device demand outlook is expected to scale up to around US$ 21.5 Bn by 2031. The microfluidic devices industry expanded at a CAGR of 12% over the past 5 years.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2995

Globally, the microfluidic devices market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare.

Globally, the microfluidic devices market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare.

Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. In addition, microfluidic proteomic devices are increasingly being used to quantify and identify proteins and to study interactions of different proteins with reagent in array. Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices.

Some of the major players in the microfluidic device market:
• Roche Diagnostics.
• Abbott Laboratories.
• Siemens Healthcare.
• Agilent Technologies.
• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation.
• Johnson & Johnson.

In North America, rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Usage of microfluidic technology in North America is high compared to other regions of the world due to its early adoption and multiple applications in different industries.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2995

In Europe, the microfluidic devices market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of microfluidic devices in the region.

However, Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems. Asia is one of the producers of generic drugs, which require microfluidic devices for toxicity testing of drugs.
The microfluidic devices market is segmented as follows:

Microfluidic Devices Market by Material
• Glass
• Polymer
• Silicon

Microfluidic Devices Market by Application
• Clinical and veterinary diagnostics
• Point of care testing
• Pharmaceutical and life science research
• Drug delivery
• Analytical devices
• Environment and industrial

Microfluidic Devices Market by Industry
• In-vitro diagnostics
• Pharmaceuticals
• Medical devices

Key geographies evaluated in this report are:
North America - U.S, Canada
Europe - France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS
APAC - China, India, Japan, Australia, Others
Latin America - Argentina, Brazil, Others

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.